HEART Camp: Promoting Adherence to Exercise in Patients With Heart Failure

Sponsor
University of Nebraska (Other)
Overall Status
Completed
CT.gov ID
NCT01658670
Collaborator
National Heart, Lung, and Blood Institute (NHLBI) (NIH), Wayne State University (Other), Henry Ford Health System (Other), University of Nebraska Lincoln (Other)
245
3
2
71
81.7
1.2

Study Details

Study Description

Brief Summary

The purpose of this study is to determine the efficacy of the Heart Failure Exercise and Resistance Training (HEART) Camp behavioral exercise training intervention on long-term adherence to exercise at 18 months in patients with heart failure. The central hypothesis is that the HEART Camp intervention group (HC) will have significantly better adherence to exercise at 18 months.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Enhanced Usual Care Group
  • Behavioral: HEART Camp (HC) Intervention Group
N/A

Detailed Description

The objective of this prospective randomized two-group repeated measures experimental design is to determine the efficacy of the HEART (Heart Failure Exercise and Resistance Training) Camp behavioral exercise training intervention on long-term adherence to exercise at 18 months in patients with HF. A sample size of 246 subjects with heart failure will be recruited over a 3 year period. All subjects will receive a cardiopulmonary exercise test and 9 supervised exercise training sessions during a 3 week run-in period prior to randomization. Subjects completing 6 of 9 training sessions will be randomized to the HEART Camp Intervention group (HC) or to an enhanced usual care (EUC) exercise group. The HC intervention group will receive cognitive-behavioral strategies that address the intervention components of knowledge, attitudes, self-efficacy, behavioral self-management skills and social support. The EUC group is provided access to the exercise facility and regular facility staff for the 18 month study period. Our central hypothesis is that the HC group will have significantly better adherence to exercise at 18 months. We will test our hypothesis with the following Specific Aims: Aim 1. To evaluate the effect of HEART Camp on adherence to exercise (measured by self-report and validated by heart rate monitor); Aim 2. To evaluate which components of the HEART Camp intervention mediate the effects of the intervention on adherence; Aim 3. To evaluate the effect of HEART Camp on specific health outcomes; Aim 4. To explore selected demographic variables (age, race, gender, body mass index and left ventricular ejection fraction) as potential moderators of the effect of the HEART Camp intervention on adherence; and Aim 5. To explore the perceptions and experiences that contextualize exercise adherence.

Study Design

Study Type:
Interventional
Actual Enrollment :
245 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Supportive Care
Official Title:
HEART Camp: Promoting Adherence to Exercise in Patients With Heart Failure
Study Start Date :
Apr 1, 2012
Actual Primary Completion Date :
Dec 1, 2016
Actual Study Completion Date :
Mar 1, 2018

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Enhanced Usual Care (EUC) exercise group

The EUC group is provided paid access to the exercise facility and has access to regular facility staff for the 18 month study period.

Behavioral: Enhanced Usual Care Group
The EUC group is provided access to the exercise facility and regular facility staff for the 18 month study period.

Experimental: HEART Camp (HC) Intervention group

The HC intervention group will be provided paid access to the exercise facility for the 18 month study period and will also receive the cognitive-behavioral intervention (knowledge, attitudes, self-efficacy, behavioral self-management skills and social support) delivered using both group-based and individual-based strategies.

Behavioral: HEART Camp (HC) Intervention Group
The HC intervention group will be provided access to the exercise facility for the 18 month study period and will also receive the cognitive-behavioral intervention (knowledge, attitudes, self-efficacy, behavioral self-management skills and social support) delivered using both group-based and individual-based strategies.

Outcome Measures

Primary Outcome Measures

  1. Adherence to exercise. [18 months]

    Adherence to exercise with 18 months as the primary outcome time point.

Eligibility Criteria

Criteria

Ages Eligible for Study:
19 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Diagnosis of heart failure (stage C chronic HF confirmed by echocardiography and clinical evaluation)

  • 19 years of age or greater

  • able to speak and read English

  • telephone access in home

  • Stable pharmacologic therapy per guidelines for past 30 days

Exclusion Criteria:
  • clinical evidence of decompensated HF

  • unstable angina pectoris

  • myocardial infarction, coronary artery bypass surgery, or biventricular pacemaker within the past 6 weeks

  • orthopedic or neuromuscular disorders preventing participation in aerobic exercise and strength/resistance training

  • participation in 3 times per week aerobic exercise during the past 8 weeks

  • cardiopulmonary stress test results that preclude safe exercise training

  • plans to move more than 50 miles from the exercise site within the next year

  • peak oxygen uptake (pVO2) in women>21mL kg min and in men >24mLkg min

  • planned or current pregnancy

Contacts and Locations

Locations

Site City State Country Postal Code
1 Henry Ford Health System Detroit Michigan United States 48202
2 Wayne State University Detroit Michigan United States 48202
3 University of Nebraska Medical Center College of Nursing Omaha Nebraska United States 68198-5330

Sponsors and Collaborators

  • University of Nebraska
  • National Heart, Lung, and Blood Institute (NHLBI)
  • Wayne State University
  • Henry Ford Health System
  • University of Nebraska Lincoln

Investigators

  • Principal Investigator: Bunny J Pozehl, PhD, RN, University of Nebraska

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Bunny J. Pozehl, Professor, University of Nebraska
ClinicalTrials.gov Identifier:
NCT01658670
Other Study ID Numbers:
  • 608-11-FB
  • 1R01HL112979
First Posted:
Aug 7, 2012
Last Update Posted:
Mar 4, 2019
Last Verified:
Feb 1, 2019
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Keywords provided by Bunny J. Pozehl, Professor, University of Nebraska
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 4, 2019